The interaction between the methyl thiosemicarbazide derivative ETS2 and Human Serum Albumin (HSA) -the main vehicle of biodistribution of small molecules in the human bloodstream -was evaluated by multiple spectroscopic techniques (circular dichroism, steady state, time-resolved, synchronous and 3D fluorescence) under physiological conditions, combined with theoretical calculations (molecular docking). The interaction HSA:ETS2 is spontaneous, moderate and is already present in the ground state (static association). Increasing the temperature leads to an increase in binding and the association is entropically driven. The secondary structure of the protein does not suffer significant perturbation upon ligand binding, however, there is a perturbation on the microenvironment around the Trp-214 residue. Sudlow's site I is the main binding site and molecular docking results suggest hydrogen bonding and hydrophobic interactions as the main binding forces. Overall, the presence of the methyl group in the ligand structure does not change significantly the protein structure, however, the presence of this group changed the thermodynamic profile, which strongly suggests that the methyl group decreases the binding ability of the thiosemicarbazide towards serum albumin.
Introduction
Proteins are the most abundant and versatile macromolecules in living systems and essentially participate in most of the biological processes. Globular proteins, which are usually known to bind to other molecules to form molecular aggregates and to catalyze biochemical reactions, are generally used as functional ingredients in health care and pharmaceutical products 1 . Human Serum albumin (HSA) is one of the main watersoluble proteins in the human bloodstream, accounting for about 60% of the total plasma proteins (42 mg mL -1 ). Among its functions stands out the biodistribution of different classes of exogenous and endogenous molecules, an important factor in the pharmacokinetic behavior of many drugs 2 . HSA has a molecular mass around 66 KDa and its structure is composed by 585 amino acid residues which form three helical domains (I, II and III) and each domain is comprised of two subdomains (A and B) 3 . The HSA structure has only one tryptophan residue (Trp-214), located in subdomain IIA, also known as Sudlow's site I or warfarin binding site. This amino acid residue is often used for the association studies of albumin with different classes of small molecules by fluorescence spectroscopic techniques 4 .
The monovalent methyl group is derived from methane through the removal of a hydrogen atom. Although the methyl group only participates in London dispersion interactions, which are the weakest of all intermolecular interactions, its presence is very important, mainly due to participation in molecular recognition on micromolecules and biomacromolecules, thereby leading to diverse biological effects, including selectivity among bioreceptors. Therefore, the stereoelectronic changes promoted by methyl groups are directly involved in many biological processes 6, 7 .
(ETS1 - Fig. 1 ) and its methyl derivative (Z)-Nmethyl-2-(3-(phenethylamino)-but-2-enoyl)-hydrazine carbothioamide (ETS2 - Fig. 1 8 .
The aim of the present study is to elucidate the methyl effect on the interaction between ETS2 and HSA, by multiple spectroscopic (circular dichroism, steady state, time-resolved, synchronous and 3D fluorescence) techniques combined with theoretical calculations (molecular docking). 
Experimental

Materials
Human serum albumin, warfarin, ibuprofen, digitoxin and PBS buffer (pH = 7.4) were purchased from Sigma-Aldrich. Methanol (spectroscopic grade) was purchased from Vetec Química (Brazil). The thiosemicarbazide ETS2 was synthesized and characterized according to a previous publication 8 .
Methodology for spectroscopy measurements
Steady-state fluorescence spectra were measured on a Jasco J-815 spectrometer, in a 1 cm x 1 cm quartz cell, employing a Jasco PFD-425S15F thermostatic cuvette holder. All spectra were recorded with appropriate background corrections. In order to compensate for the inner filter effect from ETS2, the fluorescence intensity was corrected at λ = 280 nm and 340 nm, according to equation 1 9 : (1) where Fcor and Fobs are the corrected and observed fluorescence intensity values, respectively. Aex and Aem are the experimental absorbance values at the excitation (ε = 9247 M -1 cm -1 in PBS at 280 nm) and emission wavelengths (ε = 1215 M -1 cm -1 in PBS at 340 nm), respectively.
Steady-state fluorescence spectra were measured in the 300-450 nm range, at 296 K, 303 K and 310 K, with excitation wavelength at 280 nm. Firstly, the spectrum for a 3.0 mL solution containing HSA (1.00x10 -5 M, in PBS solution at pH = 7.4) was recorded. Then, the fluorescence emission spectrum of solutions resulting from successive addition of aliquots from a stock solution of ETS2 (1. Synchronous fluorescence (SF) and 3D fluorescence spectra were obtained from a spectrofluorimeter model Xe900 from Edinburgh Instruments. SF spectra for HSA (1.00x10 -5 M) were recorded with increasing concentrations of ETS2, in the same concentration range used in the steady-state fluorescence studies. The spectra were recorded in the 240-320 nm range by setting Δλ=60 nm and Δλ = 15 nm for tryptophan and tyrosine residues, respectively, at room temperature (ca 298 K). 3D fluorescence spectra of HSA were recorded in the absence and presence of ETS2, using an excitation wavelength range of 200-340 nm and emission wavelength range of 210-460 nm, at room temperature (ca 298 K). 3D spectra were recorded for 3.0 mL of HSA solution (1.00x10 -5 M, at pH=7. 
where ϴ is the observed CD (in millidegrees), n is the number of amino acid residues (585 for HSA) 10 l is the path length of the cell (in cm) and Cp is the molar concentration of HSA (1.00x10 -6 M).
In order to investigate possible perturbation on HSA structure in the presence of methanol-solvent used for ETS2 -, steady-state fluorescence and circular dichroism spectra of HSA were recorded without and in the presence of 40 µL of methanol and no significant effect was observed.
Methodology for molecular docking calculations
The crystallographic structure of HSA was obtained from the Protein Data Bank (PDB) with access code 1N5U 11 . The thiosemicarbazide ETS2 structure was built and energy-minimized with the Density Functional Theory (DFT) method Becke-3-Lee Yang Parr (B3LYP) with the standard 6-31G* basis set available in the Spartan '14 program (Wavefunction, Inc.).
Molecular docking was performed with the GOLD 5.2 program (CCDC). Hydrogen atoms were added to the protein according to the data inferred by the program on the ionization and tautomeric states. Docking interaction cavities explored for the docking procedure were delimited by a 10 Å radius from the Trp-214 residue. The number of genetic operations (crossover, migration, mutation) in each docking run used in the searching procedure was set to 100,000 and during each docking run the amino acid residues were considered as static. The program optimizes hydrogen-bond geometries by rotating hydroxyl and amino groups of the amino acid side chains. The scoring function used was 'ChemPLP', which is the default function of the GOLD 5.2 program 12 . For more details on molecular docking procedure, see previous publications 4, 9 .
Results and Discussion
Binding ability between HSA and ETS2 Fluorescence spectroscopic techniques are essential research devices in biochemistry and biophysics, used to measure protein-drug interactions. A number of molecular interactions can result in a quenching process, which can include excited state reaction, molecular rearrangements, ground-state complex formation, collisional quenching, etc 13 . The fluorescence spectra of HSA in the absence and presence of ETS2 are given in Fig. 2 . The maximum fluorescence emission of HSA (340 nm) decreases upon successive additions of ETS2 indicating that the ligand should be located near the Trp-214 residue 4 . , indicating that the fluorescence quenching must be occurring via a static process. Thus, there is a nonfluorescent association between the fluorophore (Trp-214 residue) and thiosemicarbazide ETS2 in the ground state 16 . In order to further confirm which type of fluorescence quenching mechanism is involved in the HSA: ETS2 interaction, time-resolved fluorescence measurements were carried out for HSA without and in the presence of the ligand. The main HSA fluorophore is the Trp-214 residue, which showed two main fluorescence lifetimes (Fig. 3) : τ1 = 1.86±0.16 ns with a 21.2% contribution and τ2 = 5.78±0.13 ns with a 78.8% contribution (χ 2 = 1.175), in full agreement with literature results 17 . In the presence of ETS2, the HSA fluorescence lifetimes were τ1 = 1.84±0.15 ns with a 22.6% contribution and τ2 = 5.74±0.11 ns with a 77.4% contribution (χ 2 = 1.152). Since the fluorescence lifetimes of free HSA and HSA associated with ETS2 are the same, within the experimental error, it can be concluded that the fluorescence quenching mechanism is static, which implies a ground-state association between the tryptophan residue in HSA and ETS2. These results are in total accordance with those shown above for the steady-state fluorescence quenching (ground-state association, Table 1) 18,19 . The same trend was reported for the thiosemicarbazide ETS1 8 , from which it can be concluded that the presence of the methyl group in the ligand ETS2 structure does not change the fluorescence quenching mechanism 
where F0 and F are the fluorescence intensity of the protein sample in the absence and in the presence of the quencher, respectively. Ka is the modified Stern-Volmer binding constant; ƒ is the fraction of the initial fluorescence intensity that corresponds to the fluorophore that is accessible to the quencher and [Q] the ETS2 concentration. As can be seen in Table 1 , the Ka values are of the order of 10 4 M -1 , indicating a moderate interaction between HSA and ETS2 4, 19, 20 . The increase in Ka values with increasing temperature, suggests that at higher temperatures the increased mobility inside the serum albumin structure allows ETS2 to find improved binding within the protein pocket. This result is the opposite for ETS1 8 , suggesting that the presence of the methyl group in the thiosemicarbazide structure can stabilize the ligand binding at a higher temperature, probably due to an hydrophobic interaction between the methyl group and the amino acid residues present in the protein pocket.
In general, four representative interaction forces, namely hydrophobic force, hydrogen bond, van der Waals force, and electrostatic interactions, exist between small molecules and biological macromolecules and thermodynamic parameters (enthalpy change -ΔH° -and entropy change -ΔS°) can be used as evidence to identify the main binding forces between ligand and protein. In order to determine ΔH° and ΔS° values for the association between HSA and ETS2, the van't Hoff analysis (inset in Fig. 4 and equation 5A ) can be applied 21 . In addition, the spontaneity of the binding process can be calculated with Gibb's free energy equation (equation
where Ka is the modified Stern-Volmer binding constant at the corresponding temperature, R represents the gas constant (8.314x10
-3 kJmol -1 K -1 ), T is the temperature (296 K, 303 K and 310 K) and ΔG°, ΔH° and ΔS° are Gibb's free energy, enthalpy and entropy changes, respectively. Table 1 shows negative ΔG° values for HSA:ETS2, which is in accordance with the spontaneity of the binding process. In this case, only the entropy change value is responsible for the major contribution to the negative sign of ΔG°, indicating that the interaction HSA:ETS2 is entropically driven 9 . For the sample without the methyl group, the binding was enthalpically and entropically driven 8 . Ross and Subramanian have characterized the sign of the thermodynamic parameters with various kinds of interaction which may take place in the protein association process 22 . Table 1 shows that both ΔH° and ΔS° values are positive, indicating hydrogen bonding and hydrophobic interactions as the main binding forces in the binding process. From the standpoint of water structure, positive entropy is often regarded as a typical signature of hydrophobic interactions, since the water molecules which are arranged in an orderly fashion around the ligand and the protein molecules acquire a more random configuration as a result of hydrophobic interactions 16 .
Conformational investigation of HSA without and in the presence of ETS2
In order to determine the presence of a possible perturbation on the secondary structure of the albumin upon ETS2 binding, circular dichroism (CD) experiments were carried out at pH = 7.4 and 310 K. The CD spectrum of HSA exhibited two negative bands in the UV region, which are characteristic of the α-helical structure: 208 (π-π* transition) and 222 nm (n-π* transition) 10 . Fig. 5A shows a clear decrease in the CD signal upon the addition of ETS2, indicating that there is a perturbation on the secondary structure of the albumin upon ligand binding. The quantitative α-helical content of free HSA, as well as bound to ETS2 can be calculated from the molar residual ellipticity (MRE) values at 208 and 222 nm -equation 6 16 :
where MRE208 and MRE222 are the observed MRE value at 208 and 222 nm, respectively; 4,000 and 2,340 are the MRE values of the β-form and random coil conformation cross at 208 and 222 nm respectively, and 33,000 and 30,300 are the MRE values of a pure α-helix at 208 and 222 nm, respectively 23, 24 . Quantitatively, the α-helix percent decreases gradually, from 58.6% in free HSA to 57.4% upon ETS2 binding, at 208 nm. Similarly, at 222 nm, the α-helix percent decreases gradually, from 55.6% in free HSA to 54.2%. The CD results indicate a very weak perturbation of the albumin structure upon binding with the ETS2 ligand, indicating that binding does not affect significantly the α-helical content 25 , a result similar to that found for ETS1 8 .
Synchronous fluorescence (SF) spectroscopy is widely used to describe the interaction between a fluorescence quencher and proteins because it can provide information about the molecular environment in the vicinity of the functional fluorophore group. SF spectra are obtained by simultaneously scanning excitation and emission monochromators (Δλ). When Δλ = 15 and 60 nm characteristic information on the polarity in the microenvironment around tyrosine (Tyr) and tryptophan (Trp) residues, respectively, can be obtained 26 . SF spectra of HSA with different concentrations of ETS2 at Δλ of 15 nm and 60 nm are shown in Fig 5. The maximum fluorescence emission wavelength for the Tyr residue (Fig. 5B) shows no significant shift upon successive addition of ETS2, indicating that the microenvironment around this residue is not disturbed by the presence of the thiosemicarbazide under study 18 .
On the other hand, there is a significant shift from 275 to 280 nm on the maximum emission wavelength for  = 60 nm - Fig. 5C ), which implies that interaction of ETS2 with HSA affects the conformation of the region around the Trp residue 27 . This phenomenon was also observed for the thiosemicarbazide ETS1 which does not contain the methyl group in its structure 8 and, therefore, both ETS1 and ETS2 affect weakly the secondary structure of the protein and the conformation in the region around the Trp residue.
Three-dimensional fluorescence spectroscopy (3D) can provide detailed information on the structural changes of the polypeptide backbone, as well as possible changes on the polarity of the microenvironment around the fluorophore residues through changes in the peak positions. 3D fluorescence spectra for HSA presents two peaks: peak I, which corresponds to π-π* transition of the C=O and peak II, which corresponds to π-π* transition of the fluorophores 28 . Peaks "a" (λex = λem) and "b" (2λex = λem) are referred as Rayleigh and second-order scattering peaks, respectively 29 . The corresponding 3D spectra and its contour map for HSA in the absence or in the presence of ETS2 are shown in Fig.  6 . As can be seen in the Table 2 , the fluorescence intensity of peaks I and II decreases with the addition of ETS2 -5.59% and 4.45%, respectively. A weak change in the position of the emission wavelength (red Stokes' shift) may also be observed, suggesting possible perturbations in the polypeptide backbone as a result of the association between HSA and ETS2 near the tryptophan residue 8 . These results are in full agreement with the SF and CD data already discussed above. 
Analysis of the main binding pocket of HSA to ETS2
There are three main binding sites located in HSA structure. Sudlow's site I is located in subdomain IIA (warfarin binding site), while Sudlow's site II is located in subdomain IIIA (ibuprofen binding site) and site III in subdomain IB (digitoxin binding site) 28, 30 . Competitive binding studies were carried out in order to identify the main binding site in HSA structure to ETS2. The binding replacement was analyzed according to the modified Stern-Volmer plot (Fig. 7A) . In order to offer more details about the interaction between ETS2 and HSA inside Sudlow's site I, molecular docking exercise was carried out.
In agreement with the experimental results, molecular docking suggests that ETS2 is able to be accommodated in the cavity next to the Trp-214 residue presenting a favorable interaction profile with the amino acid residues present in the cavity via hydrogen bonding and hydrophobic forces (Fig. 7B) . One of the hydrogen atoms from the N-H group of the ligand structure is a potential donor for hydrogen bonding with the carboxyl group of Asp-450 residue, within a distance of 2.10 Å, while the hydroxyl group of Ser-453 residue is a donor for hydrogen bonding with the oxygen atom of the ligand structure within a distance of 2.10 Å. The fluorophore Trp-214 residue is hydrogen bonding with one of the nitrogen atoms from the ETS2 structure within a distance of 3.60 Å, but not with the sulfur group as reported for ETS1 8 . Finally, molecular docking also suggests hydrophobic interactions between ETS2 and the Ala-209, Val-342, Pro-446 and Leu-480 residues.
Overall, the molecular docking results suggest that the presence of the methyl group in the ligand structure changed the position of the thiosemicarbazide derivative inside albumin binding pocket, affecting mainly the interaction of Trp-214 and Asp-450 residues. The methyl group in the ligand structure interacts via hydrophobic forces with the Pro-446 residue. 
Conclusions
The methyl thiosemicarbazide derivative ETS2 binds moderately with HSA in Sudlow's site I (subdomain IIA) and causes a weak perturbation on the secondary structure of the albumin. The KSV, kq and fluorescence lifetime values suggested that the fluorescence quenching of the intrinsic fluorophore of the albumin (Trp-214) is via a static mechanism, indicating a ground state association HSA:ETS2. Thermodynamic parameters showed the spontaneity of the binding process (ΔG° < 0), which is entropically driven (ΔS° > 0). SF suggested that ETS2 does not have any effect on the polarity around the Tyr residue; however, it can perturb the microenvironment around the Trp residue. Molecular docking results suggested hydrogen bonding and hydrophobic interactions as the main binding forces between ETS2 and Ala-209, Trp-214, Val-342, Pro-446, Asp-450, Ser-453 and Leu-480 residues. Overall, ETS2 can also be carried and biodistributed in the human bloodstream by the serum albumin. However, the experimental results showed that the presence of the methyl group in the ligand structure changed the thermodynamic profile, suggesting that this group decreases the binding ability towards serum albumin. Molecular docking suggested that the presence of the methyl group in ETS2 changed the position of the thiosemicarbazide derivative inside the albumin binding pocket affecting mainly the interactions with the Trp-214 and Asp-450 residues, which were weakened. 
